BRIEF published on 10/03/2024 at 18:35, 1 year 5 months ago Poxel announces its financial and strategic results for 2023 Financial Results Biopharmaceutical TWYMEEG® Poxel OrbiMed
PRESS RELEASE published on 10/03/2024 at 18:30, 1 year 5 months ago Informations privilégiées / Communiqué sur comptes, résultats Poxel publie ses résultats financiers pour l'année 2023 et dresse un bilan de ses activités. Accord avec OrbiMed, webinaires de présentation et perspectives de croissance Résultats Financiers Croissance Webinaires Poxel OrbiMed
BRIEF published on 09/30/2024 at 07:35, 1 year 5 months ago Poxel Secures $50M Non-Dilutive Financing from OrbiMed Non-dilutive Financing TWYMEEG® Poxel Royalty Monetization OrbiMed
BRIEF published on 09/30/2024 at 07:35, 1 year 5 months ago Poxel obtient un financement non dilutif de 50 millions de dollars auprès d'OrbiMed Financement Non Dilutif TWYMEEG® Poxel Monétisation Des Redevances OrbiMed
PRESS RELEASE published on 09/30/2024 at 07:30, 1 year 5 months ago Inside Information / Other news releases Poxel monetizes TWYMEEG® royalties in a USD 50 million deal with OrbiMed. Proceeds to reduce debt and support rare disease activities. Webinars scheduled for investor updates Webinars Royalties TWYMEEG® Poxel OrbiMed
BRIEF published on 09/09/2024 at 07:35, 1 year 6 months ago POXEL annonce une hausse significative de ses ventes au deuxième trimestre 2024 Partenariats Trésorerie Ventes TWYMEEG® Poxel
BRIEF published on 09/09/2024 at 07:35, 1 year 6 months ago POXEL announces a significant increase in its sales in the second quarter of 2024 Sales Treasury Partnerships TWYMEEG® Poxel
PRESS RELEASE published on 09/09/2024 at 07:30, 1 year 6 months ago Informations privilégiées / Autres communiqués Poxel annonce ses chiffres pour le T2 et S1 2024, avec hausse des ventes de TWYMEEG® au Japon et bilan des activités. Discussions en cours pour monétisation des redevances et horizon financier solide Chiffre D'affaires Japon Poxel TWYMEEG Redevances
BRIEF published on 08/16/2024 at 08:16, 1 year 7 months ago Poxel : Évolution du Capital Social et du Nombre de Droits de Vote Droits De Vote Capital Social Actions AMF Poxel
BRIEF published on 08/16/2024 at 08:16, 1 year 7 months ago Poxel: Evolution of the Share Capital and the Number of Voting Rights Share Capital Voting Rights Actions AMF Poxel
Published on 03/26/2026 at 00:40, 1 hour 37 minutes ago Challenger RC Resource Upgrade Drilling Complete
Published on 03/26/2026 at 00:30, 1 hour 47 minutes ago Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results
Published on 03/25/2026 at 19:15, 7 hours 2 minutes ago Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/25/2026 at 13:30, 12 hours 47 minutes ago Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada
Published on 03/25/2026 at 13:30, 12 hours 47 minutes ago Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification
Published on 03/26/2026 at 01:05, 1 hour 12 minutes ago Blokees Announces Upgrade Brand Mission at 2026 Global Partner Conference
Published on 03/25/2026 at 20:00, 6 hours 17 minutes ago Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press
Published on 03/25/2026 at 19:41, 6 hours 36 minutes ago EQS-Adhoc: STRATEC POSTS IMPAIRMENTS, REPORTS PRELIMINARY RESULTS FOR 2025, AND OFFERS GUIDANCE FOR 2026
Published on 03/25/2026 at 19:30, 6 hours 47 minutes ago AIXTRON to expand global footprint with new plant in Malaysia
Published on 03/25/2026 at 19:26, 6 hours 51 minutes ago EQS-Adhoc: AIXTRON SE to expand global footprint with new plant in Malaysia
Published on 03/25/2026 at 18:53, 7 hours 23 minutes ago CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026
Published on 03/25/2026 at 18:31, 7 hours 46 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 18:31, 7 hours 46 minutes ago Performance soutenue des Investissements et déploiement actif de la stratégie
